Camtosun, A. Et Al. 2016. Are neutrophil-lymphocyte and platelet-lymphocyte ratios valuable in predicting prostate cancer?. ARCHIVES OF CLINICAL AND EXPERIMENTAL SURGERY , vol.5 , 194-199.

Camtosun, A., Celik, H., Cakmak, B., Tasdemir, C., Altintas, R., & Colak, C., (2016). Are neutrophil-lymphocyte and platelet-lymphocyte ratios valuable in predicting prostate cancer?. ARCHIVES OF CLINICAL AND EXPERIMENTAL SURGERY , vol.5, 194-199.

Camtosun, AHMET Et Al. "Are neutrophil-lymphocyte and platelet-lymphocyte ratios valuable in predicting prostate cancer?," ARCHIVES OF CLINICAL AND EXPERIMENTAL SURGERY , vol.5, 194-199, 2016

Camtosun, AHMET Et Al. "Are neutrophil-lymphocyte and platelet-lymphocyte ratios valuable in predicting prostate cancer?." ARCHIVES OF CLINICAL AND EXPERIMENTAL SURGERY , vol.5, pp.194-199, 2016

Camtosun, A. Et Al. (2016) . "Are neutrophil-lymphocyte and platelet-lymphocyte ratios valuable in predicting prostate cancer?." ARCHIVES OF CLINICAL AND EXPERIMENTAL SURGERY , vol.5, pp.194-199.

@article{article, author={AHMET ÇAMTOSUN Et Al. }, title={Are neutrophil-lymphocyte and platelet-lymphocyte ratios valuable in predicting prostate cancer?}, journal={ARCHIVES OF CLINICAL AND EXPERIMENTAL SURGERY}, year=2016, pages={194-199} }